These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

931 related items for PubMed ID: 25955972

  • 1. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X, Griffith CC, Zhou X, Wang Z, Yan Y, Li Z, Zhao C.
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [Abstract] [Full Text] [Related]

  • 2. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B, Li Z, Griffith CC, Yan S, Chen C, Ding X, Liang X, Yang H, Zhao C.
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [Abstract] [Full Text] [Related]

  • 3. Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study.
    Zhao C, Li Z, Nayar R, Levi AW, Winkler BA, Moriarty AT, Barkan GA, Rao J, Miller F, Fan F, Zhou Z, Si Q, Fischer AH, Sturgis CD, Jing X, Marshall CB, Witt BL, Birdsong GG, Crothers BA.
    Arch Pathol Lab Med; 2015 Feb; 139(2):184-8. PubMed ID: 24694342
    [Abstract] [Full Text] [Related]

  • 4. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA, Mody DR, Tams KC, Thrall MJ.
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [Abstract] [Full Text] [Related]

  • 5. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
    Li Z, Austin RM, Guo M, Zhao C.
    Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
    Alexander C, White M, Maleki Z, Rodriguez EF.
    Acta Cytol; 2019 Dec; 63(5):417-423. PubMed ID: 31195388
    [Abstract] [Full Text] [Related]

  • 8. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
    Ge Y, Christensen PA, Luna E, Armylagos D, Xu J, Hsu JW, Zhou H, Schwartz MR, Mody DR.
    Cancer Cytopathol; 2019 Dec; 127(12):757-764. PubMed ID: 31589379
    [Abstract] [Full Text] [Related]

  • 9. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C, Elishaev E, Yuan KH, Yu J, Austin RM.
    Cancer; 2007 Oct 25; 111(5):292-7. PubMed ID: 17879368
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
    Miller RA, Waters LL, Mody DR, Tams KC.
    Arch Pathol Lab Med; 2015 Jun 25; 139(6):776-81. PubMed ID: 26030246
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.
    Tao X, Austin RM, Zhang H, Zhang L, Xiao J, Zhou X, Wang L, Zhao C.
    Cancer Cytopathol; 2017 Dec 25; 125(12):947-953. PubMed ID: 28885778
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
    Zhao C, Li Z, Austin RM.
    Am J Clin Pathol; 2013 Jul 25; 140(1):47-54. PubMed ID: 23765533
    [Abstract] [Full Text] [Related]

  • 16. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M, Berkowitz Z, Yabroff KR, Wideroff L, Kobrin S, Benard V.
    Arch Intern Med; 2010 Jun 14; 170(11):977-85. PubMed ID: 20548011
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institution.
    Patadji S, Li Z, Pradhan D, Zhao C.
    Cancer Cytopathol; 2017 Mar 14; 125(3):205-211. PubMed ID: 28060456
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.